The FSP1 axis offers potential for treatment sensitisation; blocking FSP1 in chemoresistant tumours or ectopic endometriotic stromal cells may reveal ferroptosis sensitivity in a targeted fashion while maintaining gamete functionality. Here, AIFM2 is linked to neoplasm.